VADACCA, MARTA
 Distribuzione geografica
Continente #
AS - Asia 241
NA - Nord America 96
EU - Europa 71
SA - Sud America 7
AF - Africa 1
OC - Oceania 1
Totale 417
Nazione #
SG - Singapore 188
US - Stati Uniti d'America 95
IT - Italia 27
CN - Cina 24
HK - Hong Kong 24
GB - Regno Unito 18
NL - Olanda 10
BR - Brasile 7
DE - Germania 6
CZ - Repubblica Ceca 3
FR - Francia 3
FI - Finlandia 2
IN - India 2
AU - Australia 1
JP - Giappone 1
LU - Lussemburgo 1
MX - Messico 1
SA - Arabia Saudita 1
TR - Turchia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 417
Città #
Singapore 32
Ashburn 29
Hong Kong 24
Boardman 21
London 18
Rome 15
Shanghai 14
Council Bluffs 10
Amsterdam 9
Jaguariúna 7
Los Angeles 4
San Francisco 4
Washington 4
Brno 3
Naples 3
Guangzhou 2
Helsinki 2
Pune 2
West Jordan 2
Xingtai 2
Canberra 1
Charlotte 1
Frankfurt am Main 1
Handan 1
Lecce 1
Luxembourg 1
Mexico City 1
Montpellier 1
Munich 1
Newark 1
Riyadh 1
San Diego 1
Schaumburg 1
Shenzhen 1
Sona 1
Tokyo 1
Totale 223
Nome #
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 34
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 33
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 30
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 24
Identification of a new method to detect t cell response in type 1 diabetes 23
Leptin in immuno-rheumatological diseases 23
A novel approach to study T cell response to Ii-KEY/MHC class II epitope hybrid peptides in type 1 diabetes 21
Ii-key/MHC class II epitope hybrid technology to detect T cell response to insulin and GAD in type 1 diabetes. 21
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 20
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 20
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 19
Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology 18
Ii-key/insulin MHC class-II antigenic epitope peptides in type 1 diabetes 18
Ii-key/MHC class II epitope hybrid technology and ELISPOT as say in type 1 diabetes 18
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 16
Leptin in autoimmune mechanisms of systemic rheumatic diseases 16
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 15
Real-life survey on severe asthma patients during COVID-19 lockdown in Italy 15
Detection of T cell response to insulin and GAD in Type 1 diabetes using the Ii-Key-hybrid technique 15
Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential 13
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 13
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 10
Totale 435
Categoria #
all - tutte 5.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202219 0 0 0 0 0 0 0 0 2 1 0 16
2022/202334 1 4 0 0 16 0 1 0 1 0 11 0
2023/202478 1 8 6 4 8 32 0 0 2 3 7 7
2024/2025304 15 4 22 10 10 24 10 3 71 119 16 0
Totale 435